Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agile Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch ↗

June 29, 2023

H.C. Wainwright & Co, reiterated its buy rating on Agile Therapeutics, Inc. (NASDAQ: AGRX) this month, setting a price target of $12 per share.

Via Benzinga

The Overturning of Roe v. Wade Has Changed the Landscape of Birth Control; Smaller Companies are now an Integral Part of Care

June 28, 2023

Via ACCESSWIRE

This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023 ↗

June 26, 2023

Agile Therapeutics (NASDAQ: AGRX) announced the closing of its public offering in May.

Via Benzinga

Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members

June 26, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services

June 23, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

5 Value Stocks In The Healthcare Sector ↗

June 12, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 16, 2023

Friday's session saw 32 companies set new 52-week lows.

Via Benzinga

Agile Therapeutics – This Women's Healthcare Company's "Skinfusion" Technology Sets It Apart From Other Contraceptive Companies ↗

June 16, 2023

Al Altomari, Chairman & CEO of Agile Therapeutics (NASDAQ: AGRX) was recently interviewed by Benzinga.

Via Benzinga

Agile Therapeutics Announces the Availability of Twirla® through FPA Women’s Health

June 15, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

June 15, 2023

On Thursday, 64 companies achieved new lows for the year.

Via Benzinga

Why Agile Therapeutics Stock Is Trading Higher Today ↗

June 14, 2023

Agile Therapeutics Inc (NASDAQ: AGRX) announced an agreement with vitaCare Prescription Services, a wholly owned subsidiary of GoodRx Holdings Inc (NASDAQ: GDRX), to expand patient access and...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 14, 2023

Via Benzinga

Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket ↗

June 14, 2023

Gainers Cyxtera Technologies, Inc. (NASDAQ: CYXT) shares rose 134.6% to $0.0981 in pre-market trading after dropping 12% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 14, 2023

It's time for another dive into the biggest pre-market stock movers as investors get ready to trade shares on Wednesday morning!

Via InvestorPlace

A Look Into Healthcare Sector Value Stocks ↗

May 22, 2023

Via Benzinga

Agile Therapeutics: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Agile Therapeutics Earnings Preview ↗

May 10, 2023

Via Benzinga

Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®

June 13, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 – What Is The Hype All About? ↗

June 05, 2023

Women are itching for more birth control options that cater to their unique needs and preferences. While traditional forms of birth control – such as the pill and condoms – have been reliable options...

Via Benzinga

The Overturning of Roe v. Wade Has Changed The Landscape Of Birth Control; Smaller Companies Are Now An Integral Part Of Care ↗

June 01, 2023

The invention of birth control in the 1960s revolutionized women's health and their lives. In 2022, the contraceptive market was valued at $8.3 billion and it is projected to grow at a compound annual...

Via Benzinga

Agile Therapeutics Announces Closing of $7.5 Million Public Offering

May 25, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics Announces Pricing of $7.5 Million Public Offering

May 22, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update

May 11, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023

May 08, 2023

Live Conference Call and Webcast at 4:30 p.m. ET

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics: The CEO Of This Women's Healthcare Company That Recently Saw Revenue Growth Of 33% Speaks To Benzinga ↗

May 03, 2023

Al Altomari, Chairman & CEO of Agile Therapeutics (NASDAQ: AGRX) was recently a guest on Benzinga’s All Access.

Via Benzinga

Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023

April 28, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

April 26, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

National Instruments, Nutex Health And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

April 12, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 11, 2023

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear.

Via Benzinga

Agile Therapeutics Announces 1-For-50 Reverse Stock Split

April 10, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.